Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model
Saved in:
| Main Authors: | Tian Zeng, Xiudi Yang, Yi Wang, Dijiong Wu, Weiying Feng, Ying Lu, Xiaoqiong Zhu, Lirong Liu, Mei Zhou, Li Zhang, Yanping Shao, Honglan Qian, Feng Zhu, Yu Chen, Dan Cao, Li Huang, Xiaoning Feng, Lili Chen, Gang Zhang, Jing Le, Weiguo Zhu, Yongming Xia, Yanxia Han, Yongqing Jia, Guoyan Tian, Hui Zhou, Linjuan Xu, Xiufeng Yin, Qinli Tang, Yuefeng Zhang, Guoli Yao, Xianghua Lang, Kaifeng Zhang, Xiujie Zhou, Junbin Guo, Jinming Tu, Jianzhi Zhao, Gongqiang Wu, Huiqi Zhang, Xiao Wu, Qiulian Luo, Lihong Cao, Binbin Chu, Wei Jiang, Haiying Wu, Liansheng Huang, Meiwei Hu, Muqing He, Jingjing Zhu, Hongyan Tong, Jie Jin, Jian Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
by: Zhanna Zhang, et al.
Published: (2025-01-01) -
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study
by: Yi Zhang, et al.
Published: (2024-12-01) -
Dynamics and Patterns of a Diffusive Prey-Predator System with a Group Defense for Prey
by: Honglan Zhu, et al.
Published: (2018-01-01) -
Inhibition of JAK2 and MDM2 to treat secondary acute myeloid leukemia evolving from myelofibrosis
by: Fuping Wang, et al.
Published: (2024-12-01) -
Improvement on The Ellis and Roberts Viability Model
by: Guoyan Zhou, et al.
Published: (2016-05-01)